A definitive diagnosis of lymphoma (both Hodgkin and non-Hodgkin types) usually requires a biopsy. There are also a number of other tests that a physician may order as part of the diagnostic process. At Moffitt Cancer Center, we go to great lengths to ensure that a lymphoma diagnosis is accurate.
Moffitt’s state-of-the-art laboratories and imaging services assist our experts in diagnosing a specific type of lymphoma and its stage of progression – two crucial details needed by our lymphoma tumor board for developing an effective treatment plan.
Some of the diagnostic services offered at Moffitt include:
- Computed tomography (CAT) scan
- Positron emission tomography (PET) scan
- Flow cytometry
- FISH (fluorescence in situ hybridization) panel
- Hematopathology consultation
- Clonality studies (TCR and immunoglobulin gene rearrangement)
If a biopsy is needed to confirm a lymphoma diagnosis, we offer:
- Bone marrow aspiration and biopsy
- Excisional lymph node biopsy
- Image-guided biopsies under CT and ultrasound
Moffitt’s Malignant Hematology Program is made up of highly specialized experts – cancer treatment professionals who represent many different disciplines and are all focused exclusively on lymphoma. Within this program, our multispecialty lymphoma tumor board meets to carefully review a patient’s lymphoma diagnosis, design a comprehensive and individualized treatment plan and monitor the patient’s progress on a weekly basis. Patients under our care have access to a wide array of highly advanced lymphoma treatments, including cutting-edge therapies that are available only through our clinical trials program. This program is helping to improve patient outcomes and quality of life every day.
For more information, or to speak to one of our oncology experts about a possible lymphoma diagnosis or any other aspect of the condition, call Moffitt Cancer Center at 1-888-MOFFITT or fill out our convenient patient registration form. No referral is required.